{"schema_version":"secwatch.filing_event.v1","accession":"0001434647-25-000015","form_type":"8-K","ticker":"ZVRA","cik":"0001434647","company_name":"ZEVRA THERAPEUTICS, INC.","filed_at":"2025-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.403388+00:00","generated_at":"2026-05-16T15:40:08.407281+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Zevra appoints Alicia Secor to board; director Wendy Dixon retires","bullets":["Director Wendy Dixon resigned effective Dec 2, 2025; no disagreement with company operations.","Alicia Secor appointed to board as Class I director, term expiring at 2028 annual meeting.","Secor will serve on Compensation and Audit committees; compensation per director policy.","Secor brings 30+ years life sciences experience, including CEO roles at Atalanta and Juniper."],"urls":{"canonical":"https://secwatch.observer/filing/0001434647-25-000015","json":"https://secwatch.observer/filing/0001434647-25-000015.json","markdown":"https://secwatch.observer/filing/0001434647-25-000015.md","text":"https://secwatch.observer/filing/0001434647-25-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434647/000143464725000015/0001434647-25-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434647/000143464725000015/zvra-20251126.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T15:40:08.407281+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}